Quantitative RT-PCR (RT-qPCR) at several time points demonstrated that this fusion was already present at the time of CP diagnosis, and the burden of this fusion, which was reduced after successful chemotherapy for CML-BC, was correlated with that of BCR-ABL1 (Fig. 2c). This evidence concerns the gene ABL1 and breast cancer.